Skip to main content
Lunai Bioworks Inc. logo

Lunai Bioworks Inc. — Investor Relations & Filings

Ticker · RENB ISIN · US29350E1047 US Professional, scientific and technical activities
Open in API
Filings indexed 580 across all filing types
Latest filing 2022-08-18 Director's Dealing
Country US United States of America
Listing US RENB

About Lunai Bioworks Inc.

https://www.lunaibio.com

Lunai Bioworks Inc. is a pre-clinical stage biotechnology company that utilizes artificial intelligence for drug discovery and biodefense. The company focuses on pioneering safe and responsible generative biology to develop new therapies. By harnessing phenomics and AI, it aims to decode disease signals and translate them into treatments. Its proprietary Transformer Platform is designed to accelerate drug discovery processes. Lunai Bioworks develops medicines, diagnostics, and biodefense products, with a pipeline that includes programs for neurodegenerative conditions like Alzheimer's disease.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-08-18 English
Director's Dealing 2022
Director's Dealing
2022-08-03 English
Director's Dealing 2022
Director's Dealing
2022-07-27 English
Director's Dealing 2022
Director's Dealing
2022-07-18 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text mentions a letter to shareholders furnished as an exhibit, but the main document itself is a short report notifying about this letter. There are no financial statements or detailed financial data included. The length is 3498 characters, which is relatively short and consistent with an announcement rather than a full report. The document does not fit into categories like Annual Report, Earnings Release, or Interim Report. It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous SEC filings like Form 8-K that do not fit other categories.
2022-07-06 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text specifically mentions "Item 8.01 Other Events" and references a press release dated July 1, 2022, furnished as an exhibit. There is no detailed financial data or comprehensive report content; rather, it is an announcement of an event and a press release. The document length is 3507 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such filings that announce events or releases without containing the full report content should be classified as Regulatory Filings (RNS).
2022-07-01 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.